Tissue factor pathway inhibitor: From unknown coagulation inhibitor to major antithrombotic principle

被引：35

作者：

Lindahl, AK

机构：

[1] Department of Vascular Surgery, University of Oslo, Aker Hospital

来源：

CARDIOVASCULAR RESEARCH | 1997年 / 33卷 / 02期

关键词：

thrombosis; tissue factor pathway inhibitor;

D O I：

10.1016/S0008-6363(96)00208-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：286 / 291

页数：6

共 44 条

[21] THE ANTICOAGULANT EFFECT IN HEPARINIZED BLOOD AND PLASMA RESULTING FROM INTERACTIONS WITH EXTRINSIC PATHWAY INHIBITOR [J].

LINDAHL, AK ;

ABILDGAARD, U ;

STAALESEN, R .

THROMBOSIS RESEARCH, 1991, 64 (02) :155-168

[22]

LINDAHL AK, 1993, CIRCULATION, V88, P417

[23] TISSUE FACTOR PATHWAY INHIBITOR WITH HIGH ANTICOAGULANT ACTIVITY IS INCREASED IN POSTHEPARIN PLASMA AND IN PLASMA FROM CANCER-PATIENTS [J].

LINDAHL, AK ;

JACOBSEN, PB ;

SANDSET, PM ;

ABILDGAARD, U .

BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (06) :713-721

[24] THE PRESENT STATUS OF TISSUE FACTOR PATHWAY INHIBITOR [J].

LINDAHL, AK ;

SANDSET, PM ;

ABILDGAARD, U .

BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) :439-449

[25]

LINDAHL AK, 1993, THROMB HAEMOSTASIS, V69, P742

[26] RELEASE OF EXTRINSIC PATHWAY INHIBITOR AFTER HEPARIN INJECTION - INCREASED RESPONSE IN CANCER-PATIENTS [J].

LINDAHL, AK ;

ABILDGAARD, U ;

STOKKE, G .

THROMBOSIS RESEARCH, 1990, 59 (03) :651-656

[27]

LINDAHL AK, 1994, BLOOD COAGUL FIBRIN, V5, P819

[28]

MAAOUI A, 1993, THROMB HAEMOSTASIS, V69, P681

[29]

MOOR E, 1994, THROMB HAEMOSTASIS, V71, P707

[30]

NORDFANG O, 1991, THROMB HAEMOSTASIS, V66, P464

← 1 2 3 4 5 →